News Update

South East Asia health startup Doctor Anywhere gets $88M SGD


South East Asia health startup Doctor Anywhere gets $88M SGD in Series C funding. The round was led by Asia Partners, with participation from Novo Holdings, Philips and OSK-SBI Partners. It also included returning investors EDBI, Square Peg, IHH Healthcare, Kamet Capital and Pavilion Capital. As part of the round, Asia Partners co-founder Oliver Rippel and Novo Holdings Equity Asia senior partner Dr. Amit Kakar will join Doctor Anywhere’s board of directors. The company’s Series C, which it claims is one of the largest private rounds raised by a Southeast Asian healthtech company, brings its total funding to more than $140 million SGD. Doctor Anywhere’s omnichannel approach means that in addition to online consultations, it runs in-person clinics, provides home visits, medication deliveries and operates an in-app marketplace for health and wellness products.

Southeast 2

Founded in 2017 by Lim Wai Mun, Doctor Anywhere claims it now serves more than 1.5 million users. It is available in Singapore, Malaysia, Thailand, Vietnam and the Philippines, and recently established tech hubs in Bangalore and Ho Chi Minh City. Lim told TechCrunch in an email that when he started working on Doctor Anywhere, there were already successful telemedicine platforms in the United States, the United Kingdom and China, but the model was still nascent in Southeast Asia. A former investor, Lim began Doctor Anywhere as a side project because he had older relatives who could not leave their homes for medical visits. Doctor Anywhere launched as an online-only telehealth platform, but “we quickly realized that physical presence is very important in order to build trust with users,” Lim said. As a result, the company started its home care services and physical clinics

Follow Startup Story

Related Posts

© Startup Story Private Limited. All Rights Reserved.